Clinical trial
Effect of Hilotherapy on Quality of Life and Comfort Level in the Management of Symptoms Related to Taxane-Associated Peripheral Neuropathy in Breast Cancer Patients
NCT07345221 is registered in ClinicalTrials.gov with Nuran Ayşen Pamir Aksoy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Hilotherapy on Quality of Life and Comfort Level in the Management of Symptoms Related to Taxane-Associated Peripheral Neuropathy in Breast Cancer Patients
- Lead sponsor
- Nuran Ayşen Pamir Aksoy
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 4, 2025
- Completion date
- August 31, 2026
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
peripheric neuropathy